Genomics announced new multi year collaborations in cancer research with PharosAI, the Cancer Research Institute, and Dana Farber Cancer Institute. The partners plan to use 10x Genomics spatial ...
Investors usually find it discouraging when an analyst cuts the price target on one of their stocks. In this instance, the cut to this company's shares was rather deep. It wasn't immediately apparent ...
Genomics (TXG) is in focus as investors consider an upcoming earnings report and a new PharosAI collaboration that applies its Xenium spatial platform to large scale, AI driven cancer research ...
A member of the UCSC Braingeneers group talks with symposium attendees about their research with brain organoids. Photo Credit: Anusha Ravishankar. Twenty-five years ago, UC Santa Cruz played a ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Singular Genomics Systems, Inc. (NASDAQ: OMIC) to an affiliate of Deerfield Management ...
On 4 February 2026, PharosAI announced it would use 10x Genomics’ Xenium spatial platform to convert archived NHS cancer ...
Segun Fatumo discusses how he is working towards a true global genomics framework and strengthening African research capacity ...
Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results